Breaking news: Merck won the most recent Vioxx case in New Jersey. The jury decided Merck failred to warn of the risk of heart attack associated with Vioxx, but that failure did not cause the plaintiff’s death. The jury found no fraud or misrepresentation by Merck. Commentary to follow, as John is on the road to Seattle.
Updated: